Cancer drugs like cisplatin are designed to attack tumor cells, but new research shows these therapies can concentrate inside specialized molecular clusters within the nucleus, altering how ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

A tumor “don’t‑eat‑me” shield also hides pro‑immune danger signals; new antibodies that unmask this hidden cue could make cancers more vulnerable to immune attack.

Immunotherapy has transformed cancer treatment by harnessing the body's own immune system to fight disease. But many engineered immune cells lose strength quickly after they enter the body, especially ...

AUSTIN, TX, UNITED STATES, May 8, 2025 /EINPresswire.com/ -- A groundbreaking discovery in the fight against breast cancer was announced at the Beljanski Integrative ...

Scientists at Georgetown University's Lombardi Comprehensive Cancer Center have uncovered a new dual function for a well-known cancer-related protein called ezrin. This finding could potentially open ...

A research team led by Albert Einstein College of Medicine scientists has developed a new strategy to engineer immune cells ...

Recent advances in drug discovery research have led to the development of numerous drug candidate compounds with high ...

The American Cancer Society received a $9.1 million grant from the Lisa Dean Moseley Foundation to establish the American Cancer Society Lisa Dean Moseley Foundation Cancer Stem Cell Consortium, the ...

This might be a long shot, but I was diagnosed with triple negative breast cancer, had a lumpectomy with clear margins and had a recurrence six months later. I am struggling with the treatment regimen ...